Drugmaker Orexigen Opens Del. Ch. 11 With $226M In Debt
Obesity treatment maker Orexigen Therapeutics Inc. on Monday filed for Chapter 11 protection in Delaware, saying it is looking at a pending cash crunch and a likely near-term call to repay...To view the full article, register now.
Already a subscriber? Click here to view full article